Trial intelligence / Profile preview

HA35 in mild periodontitis

NCT05765513Completed

Sponsor
Dove Medical Press
Start
Feb 2023
Primary completion
Jul 2023
Modality
Peptides
Countries
1
01

Overview

Open-label trial of ha35 in periodontitis, sponsored by Dove Medical Press. Primary endpoint: Gingival discomfort scores at 7 days. Started Feb 2023; status: completed.

02

Drugs

ha35
03

Conditions

periodontitis

Beyond the preview

Go deeper on NCT05765513.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05765513.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call